Cargando…
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Co-infection has been reported in patients with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, but there is limited knowledge on co-infection among patients with coronavirus disease 2019 (COVID-19). The prevalence of co-infection was variable among COVID-19 patients i...
Autores principales: | Lai, Chih-Cheng, Wang, Cheng-Yi, Hsueh, Po-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245213/ https://www.ncbi.nlm.nih.gov/pubmed/32482366 http://dx.doi.org/10.1016/j.jmii.2020.05.013 |
Ejemplares similares
-
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
por: Lai, Chih-Cheng, et al.
Publicado: (2020) -
A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response
por: Lin, Yi-Chun, et al.
Publicado: (2020) -
Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023) -
SARS-CoV-2 and COVID-19
por: Sheng, Wang-Huei, et al.
Publicado: (2020) -
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
por: Lai, Chih-Cheng, et al.
Publicado: (2020)